Related Experiment Videos
Familial hypertrophic cardiomiopathy: molecular basis and genotype-phenotype correlations
G Cuda1, A Lamberti, N Perrotti
1Department of Experimental and Clinical Medicine, G. Salvatore Medical School. cuda_g@abramo.it
Insights
Molecular genetics advances early diagnosis of familial hypertrophic cardiomyopathy (FHC). Understanding genetic links to sarcomeric proteins aids in managing this inherited heart condition.
Area of Science:
- Cardiovascular Genetics
- Molecular Medicine
- Clinical Diagnostics
Background:
- Familial hypertrophic cardiomyopathy (FHC) is an inherited cardiac disorder with diverse clinical presentations.
- Genetic factors significantly influence FHC development and manifestation.
- Early and accurate diagnosis remains a challenge for clinicians.
Purpose of the Study:
- To review recent findings on the genetic basis of FHC.
- To analyze genotype-phenotype correlations in FHC.
- To highlight the role of genetic factors in FHC management.
Main Methods:
- Review of current literature on FHC genetics.
- Analysis of linkage studies identifying genetic loci associated with FHC.
- Examination of genotype-phenotype relationships.
Main Results:
- At least seven genetic loci, primarily coding for sarcomeric proteins, are linked to FHC.
- Genetic mutations are key determinants of FHC.
- Clinical expression of FHC can be influenced by modifier genes, genetic background, and environmental factors.
Conclusions:
- Molecular genetics is crucial for diagnosing and managing FHC.
- Genotype-phenotype correlations are essential for personalized FHC care.
- Further research into modulating factors will improve FHC treatment strategies.
Abstract:
The impact of molecular genetics in the diagnosis and management of various forms of heritable cardiac or vascular disorders is continuously increasing thanks to the newly available laboratory tools. Familial hypertrophic cardiomyopathy (FHC), an autosomal dominant inherited disease characterized by unexplained left ventricular hypertrophy and a wide range of clinical symptoms, is the first cardiac disorder whose genetic bases have been elucidated. Linkage analysis studies have shown a statistically significant association between the disease status and at least seven genetic loci, all coding for sarcomeric proteins, in unrelated kindreds. A major challenge for physicians is to make an accurate and early diagnosis, not only on the basis of the traditional tools (i.e. physical examination and electro-echocardiography) but also to focus on the impact of genotype on clinical manifestations of FHC. In this review we present the more recent findings on the genetic basis of FHC and analyze the genotype-phenotype correlations of this disorder, whose expression may be modulated by additional factors (modifier genes, genetic background, environmental factors) other than mutations in any of the sarcometric proteins.